Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Published:2005-05 Issue:9 Volume:171 Page:1040-1047
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Azuma Arata,Nukiwa Toshihiro,Tsuboi Eiyasu,Suga Moritaka,Abe Shosaku,Nakata Koichiro,Taguchi Yoshio,Nagai Sonoko,Itoh Harumi,Ohi Motoharu,Sato Atsuhiko,Kudoh Shoji

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference38 articles.

1. Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment

2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

3. Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis

4. Fibrotic Idiopathic Interstitial Pneumonia

5. Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia

Cited by 803 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter Study;Journal of Vascular and Interventional Radiology;2024-09

2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

3. Idiopathic pulmonary fibrosis mortality: update on trends in the modern treatment era;European Respiratory Journal;2024-08

4. Clinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study);BMC Pulmonary Medicine;2024-07-31

5. Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias;Respiratory Research;2024-07-31